Letter to the Editor
19 December 2023 / 29 May 2024 by almaware | Leave a Comment
Read more »
Original Article
12 December 2023 / 18 November 2024 by almaware | Leave a Comment
Background. Patients with autoimmune forms of chronic spontaneous urticaria (aiCSU) exhibit autoantibodies against the high-affinity IgE receptor (FcεRI) and IgE. As the presence of these autoantibodies does not correlate with disease activity, the functional affinity/avidity may be relevant in aiCSU. This exploratory study aimed to characterize the quantity and avidity of autoantibodies against IgE and […]
12 December 2023 / 29 May 2024 by almaware | Leave a Comment
Background. Patients with autoimmune forms of chronic spontaneous urticaria (aiCSU) exhibit autoantibodies against the high-affinity IgE receptor (FcεRI) and IgE. As the presence of these autoantibodies does not correlate with disease activity, the functional affinity/avidity may be relevant in aiCSU. This exploratory study aimed to characterize the quantity and avidity of autoantibodies against IgE and […]
Review
5 December 2023 / 31 May 2024 by almaware | Leave a Comment
Background. The prevalence of food allergy (FA) has increased, a possible consequenceof intestinal dysbiosis, environmental or genetic factors. Currently, no formal indications exist for probiotic or prebiotic supplementation in FA. Thisreview aims to analyze the role of probiotics and prebiotics in the prevention and treatment of FA. Methods. PubMed/Medline search was carried out on articles […]
5 December 2023 / 13 September 2024 by almaware | Leave a Comment
Background. Although biologic agents promise a short- to medium-term remission in asthma, it is unclear whether they can fundamentally alter disease course and achieve long-term remission. We aimed to investigate the clinical remission success of biologics in patients with severe asthma and the factors associated with remission. Methods. Adults followed-up due to severe asthma who […]
4 December 2023 / 29 May 2024 by almaware | Leave a Comment
Background. Metamizole, a non-steroidal anti-inflammatory drug from the pyrazolone group, is a frequent cause of immediate hypersensitivity reactions and, more rarely, of delayed drug hypersensitivity reactions. Due to its favorable pharmacokinetic characteristics, metamizole is widely used in the postoperative period for pain control. Methods. Retrospective study of patients referred for allergological study between January 2012 […]